Chembio Diagnostics DSO Ratio 2011-2026 | CEMI

Annual DSO Ratio Chembio Diagnostics

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
66.3	56.6	40.5	38.8	80.6	31.7	69.1	36.5	110	56.7	68.7	56.4

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
110	31.7	59.3

Quarterly DSO Ratio Chembio Diagnostics

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	21.4	-	51.7	-	36.9	38.1	30.3	-	30	60.3	46.8	-	34.4	33.8	58.9	-	19.5	75.1	55.9	31.8	25.1	46.2	39.5	72.6	82.4	94.5	40.1	50	32.1	32.9	78.8	-	104	103	101	-	43.6	77.7	64.3	-	87.9	72.3	53.6	-	46.2	75.7	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
104	19.5	55.4

DSO Ratio of other stocks in the Diagnostics research industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Lantheus Holdings LNTH	80.5	$ 74.6	-1.49 %	$ 5.03 B	USA
Centogene N.V. CNTG	145	-	-6.23 %	$ 30.6 M	Germany
Bioventus BVS	82.1	$ 9.28	3.11 %	$ 618 M	USA
Biodesix BDSX	41.7	$ 15.5	5.51 %	$ 2.01 B	USA
Medpace Holdings MEDP	50.4	$ 465.57	1.89 %	$ 13.4 B	USA
Akumin AKU	57.4	-	-17.87 %	$ 25.9 M	Canada
Enzo Biochem ENZ	50.3	-	-8.98 %	$ 14.8 K	USA
Oxford Immunotec Global PLC OXFD	90.8	-	-	$ 562 M	Britain
Myriad Genetics MYGN	52.3	$ 4.7	0.86 %	$ 435 M	USA
National Research Corporation NRC	29.4	$ 17.38	-0.77 %	$ 389 M	USA
DermTech DMTK	80.6	-	-11.32 %	$ 2.94 M	USA
Aspira Women's Health AWH	50.7	-	-6.19 %	$ 10.5 M	USA
Co-Diagnostics CODX	101	$ 4.4	101.83 %	$ 129 M	USA
Accelerate Diagnostics AXDX	291	-	-61.36 %	$ 2.46 M	USA
Global Cord Blood Corporation CO	112	-	-	$ 399 M	China
Fluidigm Corporation FLDM	67.2	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	11.7 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	122	-	0.12 %	$ 80.1 M	China
PRA Health Sciences, Inc. PRAH	98.1	-	-	$ 10.7 B	USA
Pacific Biosciences of California PACB	71.8	$ 1.39	-	$ 417 M	USA
Charles River Laboratories International CRL	65	$ 160.55	1.56 %	$ 7.96 B	USA
IQVIA Holdings IQV	73.9	$ 168.36	0.81 %	$ 28.9 B	USA
Biocept BIOC	112	-	-13.05 %	$ 7.29 M	USA
Invitae Corporation NVTA	242	-	-	$ 21.2 M	USA
BioNano Genomics BNGO	63.7	$ 1.21	-17.22 %	$ 6.59 M	USA
Mettler-Toledo International MTD	66.4	$ 1 268.55	2.27 %	$ 26.1 B	Schweiz
Interpace Biosciences IDXG	53.1	$ 1.71	0.73 %	$ 7.5 M	USA
Illumina ILMN	61.3	$ 126.25	1.99 %	$ 20.1 B	USA
QIAGEN N.V. QGEN	30.8	-	-	$ 10.6 B	Niderland
Precipio PRPO	28.1	$ 27.01	0.3 %	$ 35.1 M	USA
Personalis PSNL	55.8	$ 7.73	1.58 %	$ 458 M	USA
RadNet RDNT	34.5	$ 59.61	-3.45 %	$ 4.48 B	USA
Laboratory Corporation of America Holdings LH	52.9	$ 266.82	0.88 %	$ 22.2 B	USA
Motus GI Holdings MOTS	77.2	-	-34.28 %	$ 263 K	Israel
Senseonics Holdings SENS	10.3	$ 6.74	1.81 %	$ 281 M	USA
Sotera Health Company SHC	43.9	$ 13.89	0.07 %	$ 3.94 B	USA
ENDRA Life Sciences NDRA	7.11	$ 3.49	0.29 %	$ 1.87 M	USA
NeoGenomics NEO	77.7	$ 7.94	-1.98 %	$ 1.02 B	USA
Soleno Therapeutics SLNO	27	$ 30.98	-2.33 %	$ 1.57 B	USA
Natera NTRA	81.5	$ 197.02	-1.53 %	$ 19.4 B	USA
CareDx, Inc CDNA	51.5	$ 17.95	2.22 %	$ 957 M	USA
Neuronetics STIM	48.7	$ 1.49	-6.88 %	$ 98.3 M	USA
OPKO Health OPK	240	$ 1.14	-1.3 %	$ 791 M	USA
Castle Biosciences CSTL	49.2	$ 25.59	-0.62 %	$ 711 M	USA
DarioHealth Corp. DRIO	56.7	$ 7.99	6.53 %	$ 31.8 M	Israel
DexCom DXCM	87	$ 66.84	1.36 %	$ 26.1 B	USA
Exact Sciences Corporation EXAS	30.8	$ 104.91	-	$ 19.8 B	USA